“My Diagnosis Was a License to Finally Trust Myself”

“My Diagnosis Was a License to Finally Trust Myself”

When a diagnosis of ADHD and/or autism comes in mid or late life, the first thing a woman feels often isn’t relief over access to medication and accommodations. It’s something harder to name — a kind of retroactive permission to stop trying to fix something that was never broken.

I’m one of those women. I received my own ADHD and autism diagnoses as an adult, and the experience reordered how I understood the preceding three decades of my life. This emotional response is, I’d argue, one of the most important things to understand about the recent surge in late diagnoses among women. And it’s almost entirely missing from the public conversation.

The Label Does More Than Label

Research on late-diagnosed autistic women consistently documents a cluster of experiences after diagnosis: a reinterpretation of personal history, a reduction in self-blame, an increase in self-compassion, and a sense of finally being understood, both by others and by themselves. In one qualitative study, late-diagnosed women said the experience gave them greater confidence and a sense of belonging.

Another study found the same to be true for women with ADHD, who credited their diagnoses with “healing, improved self-esteem, and life feeling more worth living.”

These feelings aren’t side effects of diagnosis. For many women, they’re the primary benefit.

For us women who spent decades masking — suppressing instinctive responses, performing neurotypicality, exhausting ourselves in the effort to seem fine — diagnosis does more than deliver crucial clinical benefits. It reframes the friction we experience on a daily basis as structural, not personal. In doing so, it offers us that rarest gift: the license to trust ourselves.

[Read: A Woman’s Guide to Pursuing an AuDHD Diagnosis]

Who Gets to Access Self-Understanding?

The frustrating reality is that many women lack access to a high-quality, neurodiversity-affirming clinical assessment. A comprehensive neuropsychological evaluation can easily cost thousands of dollars out of pocket. Many insurance plans cover little or none of it. Waitlists through public systems can stretch years. And the quality of what you receive depends heavily on whether your evaluator understands how ADHD and autism present in women — which, given how recently that research has developed, is far from guaranteed.

The result is that the emotional benefits of diagnosis disproportionately accrue to middle-class and wealthy women. There are racial disparities, as well; white women are far more likely than their non-white counterparts to be diagnosed with ADHD or to be clinically identified as autistic.

The relief that diagnosis can offer isn’t a universal experience. For too many women, it remains out of reach.

The Deeper Problem

If diagnosis is delivering essential emotional benefits — validation, community, a narrative reframing of a difficult life — that is worth protecting. But it’s also worth asking why a clinical label became the primary mechanism for delivering those things in the first place.

[Read: The Transformative Power of an ADHD Diagnosis for Older Women]

Simply put: Our culture doesn’t offer many other pathways to validation. There’s no widely available, non-medicalized way to say to a woman, “Your experience of lifelong friction was real, had structural causes, and does not reflect a failure of character or effort.” Diagnosis uniquely fills that gap.

This raises the stakes for accessing diagnosis, as well as the cost of being locked out. And it points toward two distinct responses: making diagnosis itself more accessible and building other routes to the validation it currently monopolizes.

Beyond Formal Assessments

In the short term, the most direct response is to make assessment more accessible. That means expanding insurance coverage for neuropsychological evaluation, funding community-based diagnostic clinics, training more providers in how ADHD and autism present in women and girls, and reducing the cost and wait times that currently make formal diagnosis a privilege.

The longer-term work is building other pathways to the emotional and cultural benefits that diagnosis currently provides. Peer communities, where late-identified women can find recognition without requiring clinical confirmation, can deliver some of what a formal assessment does.

Psychoeducation about neurodivergence, offered outside the diagnostic process, can begin the work of reframing. Therapists and coaches trained in neurodiversity-affirming practice can help women build self-understanding and self-compassion without making diagnosis a prerequisite.

A word of caution: calling for non-medicalized alternatives is not the same as calling for them to replace diagnosis. Women who need clinical support — medication, accommodations, formal identification — deserve access to the real thing. The goal isn’t a two-tiered system where wealthy women receive diagnoses and everyone else receives peer groups as a consolation prize. It’s a world in which the emotional work of validation is accessible to anyone who needs it.

Recognizing her own neurodivergence is often one of the most relieving experiences a woman can have. It shouldn’t be a privilege. Women deserve access to their own self-understanding, and too many are still waiting for a clinical process to grant it.

ADHD in Adult Women: Next Steps


ADDITUDE IS HUMAN
Artificial intelligence does not create or edit any written content published by ADDitude. Our editorial team is 100% human, and our mission is simple: listen to and serve our readers with hand-crafted, expert-informed resources. To support ADDitude, please consider subscribing. Your readership and support help make our commitment possible. Thank you.

Nathaly Pesantez

Source link